Quantcast

Latest insulin resistance Stories

2014-05-07 10:40:44

Researchers from The Netherlands found that snacking on high-fat and high-sugar foods was independently associated with abdominal fat and fatty liver (hepatic steatosis). According to the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, hypercaloric diet with frequent meals increases intrahepatic triglyceride content (IHTG) and fat around the waist, but increasing meal size did not. Obesity is a global health concern with the World...

2014-05-07 09:50:08

Follow-up study published in the Journal of Parkinson's Disease supports an earlier 'proof of concept' trial A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. These data provide strong encouragement for the further study of this drug in patients with PD, report researchers in the Journal of Parkinson's Disease....

2014-05-06 14:45:21

New studies provide fresh evidence that the same factors that lead to diabetes contribute to low milk supply in some new mothers. In a study to be presented May 5, Cincinnati Children's Hospital Medical Center researchers discovered that problems with mothers' insulin metabolism may affect their milk production. The study found that women diagnosed with low milk supply were 2.5 times more likely to have experienced gestational diabetes compared to women seen at the clinic solely because...

2014-05-02 08:24:15

Significant reductions of more than 1,500 mg/dL in triglycerides observed CARLSBAD, Calif., May 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final data from its Phase 2 study of ISIS-APOCIII(Rx) as a monotherapy in patients with familial chylomicronemia syndrome, or FCS. In this open-label study, three patients with FCS treated with ISIS-APOCIII(Rx) achieved substantial reductions in triglycerides with all three patients achieving a triglyceride...

2014-05-01 08:34:54

- 69 percent reduction in triglycerides achieved CARLSBAD, Calif., May 1, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final results from its Phase 2 study of ISIS-APOCIII(Rx) in patients with high triglycerides and type 2 diabetes. In this study, patients treated with ISIS-APOCIII(Rx) achieved statistically significant average mean percent reduction from baseline of 88 percent (p=0.02) in apolipoprotein C-III (apoC-III) and 69 percent (p=0.02) in...

Climbing Mount Everest To Learn More About Type 2 Diabetes
2014-04-16 07:06:22

April Flowers for redOrbit.com - Your Universe Online Most people engage in extreme sports, such as climbing Mount Everest, in an attempt to gain insight about themselves. A group of researchers from the University of Southampton and University College London (UCL) climbed Mount Everest to gain new insights into the molecular process of how some people get Type II diabetes. Their findings, published in PLOS ONE, could lead to new ways of preventing people from getting the condition. The...

2014-04-15 23:12:19

Avail is conducting a 6-week, Phase 2 randomized study to assess the safety, tolerability and pharmacodynamics of a new combination therapy administered to participants with type 2 diabetes mellitus. DeLand, FL (PRWEB) April 15, 2014 *To see if you qualify for this Diabetes Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance required, and you may receive...

2014-04-14 23:08:39

Health News Wires reviews the top five ways to lower insulin resistance and what to consider when evaluating the health benefits of the best insulin resistance supplement. Boston, MA (PRWEB) April 14, 2014 A new article and video from Healthnewswires.com details signs of insulin resistance, benefits of an insulin resistant diet, and important considerations when looking for the best supplement to lower insulin resistance. Insulin resistance is a condition where the body fails to recognize...

2014-04-09 23:04:33

Diasome Pharmaceuticals, Inc. Announces Two New Board Members Cleveland, Ohio (PRWEB) April 09, 2014 Diasome Pharmaceuticals, Inc. (http://www.diasome.com) has announced that Frank McCaney, CEO of Corpak MedSystems, Inc., and Thomas McDonald, founder and CEO of McDonald Partners LLC, have joined its board of directors. Mr. McCaney’s career includes serving in senior management positions at Thermo Electron Corporation and Viasys Healthcare, where he played a lead role in spinning Viasys...

2014-04-08 08:30:26

--MBT Previously Reported Statistically Significant Positive Topline Results from this First Double-Blind, Randomized Clinical Trial of a Microbiome Modulator for Diabetes-- BROOMFIELD, Colo., April 8, 2014 /PRNewswire/ -- MicroBiome Therapeutics(TM) LLC, (MBT) today announced that data from the company's clinical trial of microbiome modulator NM504 in development for type 2 diabetes and prediabetes has been accepted for a Poster Preview Presentation at ICE/ENDO 2014, the joint...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.